Results 171 to 180 of about 933,327 (380)

Role of non-HDL-cholesterol in evaluation of dyslipidemia in preeclampsia

, 2019
R Reena, S Usha, B. M. Rupakala, HV Shetty   +3 more
openalex   +1 more source

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source

Genetics of Increased HDL Cholesterol Levels [PDF]

, 2003
Marina Cuchel, Daniel J. Rader
openalex   +1 more source

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

, 2012
P. Toth
semanticscholar   +1 more source

Causal correlations between inflammatory proteins and heart failure: A two‐sample Mendelian randomization analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1374-1385, April 2025.
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu, Gui‐Qin Liu, Ya‐Ping Peng, Li‐Ling Zhang, Xian‐Jin Wang, Liang‐Chuan Chen, Yuan‐Xi Zheng, Xue‐Jun Xiang, Rui Qiao, Xian‐He Lin   +9 more
wiley   +1 more source

Serum proteins and fractions, HDL-cholesterol and total IgG and IgE levels in cases of acute and chronic paracoccidioidomycosis [PDF]

, 2009
Audrey de Souza Marquez, Adriana Pardini Vicentini Moreira, P. C. Leonello, Fernanda Akemi Nakanishi, Eiko Nakagawa Itano   +4 more
openalex   +1 more source

Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

Science, 2016
P. Zanoni, Sumeet A. Khetarpal, Daniel B Larach, William Hancock-Cerutti, John S. Millar, M. Cuchel, S. Derohannessian, A. Kontush, P. Surendran, D. Saleheen, S. Trompet, J. Jukema, A. D. de Craen, P. Deloukas, N. Sattar, I. Ford, C. Packard, Abdullah al Shafi Majumder, Dewan S. Alam, E. di Angelantonio, G. Abecasis, Rajiv Chowdhury, J. Erdmann, B. Nordestgaard, S. Nielsen, A. Tybjærg-Hansen, Ruth Frikke Schmidt, K. Kuulasmaa, Dajiang J. Liu, M. Perola, S. Blankenberg, V. Salomaa, S. Männistö, P. Amouyel, D. Arveiler, J. Ferrières, M. Müller-Nurasyid, M. Ferrario, F. Kee, C. Willer, N. Samani, H. Schunkert, A. Butterworth, J. Howson, G. Peloso, N. Stitziel, J. Danesh, S. Kathiresan, Daniel J. Rader   +48 more
semanticscholar   +1 more source

Computer‐Aided Functional Oligosaccharide Screening and the Regulatory Role in Lipid Metabolism

Food Bioengineering, EarlyView.
ABSTRACT This study investigated the lipid‐lowering effects and intervention mechanisms of structurally diverse functional oligosaccharides on non‐alcoholic fatty liver disease (NAFLD). By integrating computational tools such as molecular docking and molecular dynamics simulations (MDS), a comprehensive “in silico‐in vitro‐in vivo” tri‐dimensional ...
Rui Jing, Shanshan Deng, Mengyao Zhao, Liming Zhao   +3 more
wiley   +1 more source

Studies on Serum HDL Cholesterol of Diabetics

, 1980
Kohnin Yamada, Hidekatu OHTA, Hiromichi Ôhara   +2 more
openalex   +2 more sources

Cholesterol-efflux capacity might be the key to the protective effects of HDL [PDF]

, 2011
Joana Osório
openalex   +1 more source